Bellevue Life Sciences Acquisition Corp.
BLAC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $51,677 | $80,724 | $91,456 | $80,093 |
| - Cash | $66 | $15 | $125 | $5 |
| + Debt | $1,763 | $0 | $1,200 | $400 |
| Enterprise Value | $53,374 | $80,709 | $92,531 | $80,488 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$3,525 | $3,720 | $193 | $233 |
| % Margin | – | – | – | – |
| Net Income | -$2,411 | $404 | -$35 | -$3 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.54 | 0.072 | -0.004 | -0 |
| % Growth | -852.1% | 1,941% | -875% | – |
| Operating Cash Flow | -$2,188 | -$819 | -$4 | -$0 |
| Capital Expenditures | $0 | -$0 | $0 | $0 |
| Free Cash Flow | -$2,188 | -$819 | -$4 | -$0 |